High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice

19Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

SLC19A3 deficiency, also called thiamine metabolism dysfunction syndrome-2 (THMD2; OMIM 607483), is an autosomal recessive neurodegenerative disorder caused by mutations in SLC19A3, the gene encoding thiamine transporter 2. To investigate the molecular mechanisms of neurodegeneration in SLC19A3 deficiency and whether administration of high-dose thiamine prevents neurodegeneration, we generated homozygous Slc19a3 E314Q knock-in (KI) mice harboring the mutation corresponding to the human SLC19A3 E320Q, which is associated with the severe form of THMD2. Homozygous KI mice and previously reported homozygous Slc19a3 knock-out (KO) mice fed a thiamine-restricted diet (thiamine: 0.60 mg/100 g food) died within 30 and 12 days, respectively, with dramatically decreased thiamine concentration in the blood and brain, acute neurodegeneration, and astrogliosis in the submedial nucleus of the thalamus and ventral anterior-lateral complex of the thalamus. These findings may bear some features of thiamine-deficient mice generated by pyrithiamine injection and a thiamine-deficient diet, suggesting that the primary cause of THMD2 could be thiamine pyrophosphate (TPP) deficiency. Next, we analyzed the therapeutic effects of high-dose thiamine treatment. When the diet was reverted to a conventional diet (thiamine: 1.71 mg/100 g food) after thiamine restriction, all homozygous KO mice died. In contrast, when the diet was changed to a high-thiamine diet (thiamine: 8.50 mg/100 g food) after thiamine restriction, more than half of homozygous KO mice survived, without progression of brain lesions. Unexpectedly, when the high-thiamine diet of recovered mice was reverted to a conventional diet, some homozygous KO mice died. These results showed that acute neurodegeneration caused by thiamine deficiency is preventable in most parts, and prompt high-dose thiamine administration is critical for the treatment of THMD2. However, reduction of thiamine should be performed carefully to prevent recurrence after recovery of the disease.

References Powered by Scopus

AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet

7329Citations
N/AReaders
Get full text

Food intake, water intake, and drinking spout side preference of 28 mouse strains

534Citations
N/AReaders
Get full text

Markers for neuronal degeneration in organotypic slice cultures

270Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The SLC transporter in nutrient and metabolic sensing, regulation, and drug development

157Citations
N/AReaders
Get full text

Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies

96Citations
N/AReaders
Get full text

Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial

69Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Suzuki, K., Yamada, K., Fukuhara, Y., Tsuji, A., Shibata, K., & Wakamatsu, N. (2017). High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice. PLoS ONE, 12(6). https://doi.org/10.1371/journal.pone.0180279

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

63%

Professor / Associate Prof. 3

19%

Researcher 3

19%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 5

38%

Neuroscience 4

31%

Pharmacology, Toxicology and Pharmaceut... 2

15%

Medicine and Dentistry 2

15%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 138

Save time finding and organizing research with Mendeley

Sign up for free